Viking Therapeutics, Inc.
VKTX
Revenue
0.00
0.000.00%
3 Months ChangeAssets
937.89M
▼-8.95M▼-0.9454%
3 Months ChangeLiabilities
26.44M
▲581.00k▲2.25%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-23
Form 10-Q
ID: 0000950170-24-116708
2024-10-23
Form 8-K
ID: 0000950170-24-116642
2024-07-24
Form 10-Q
ID: 0000950170-24-086111
2024-07-24
Form 8-K
ID: 0000950170-24-086039
2024-06-04
Form 8-K
ID: 0000950170-24-068297
2024-05-23
Form 8-K
ID: 0000950170-24-063707
2024-04-25
Form 10-Q
ID: 0000950170-24-047833
2024-04-24
Form 8-K
ID: 0000950170-24-047567
2024-03-26
Form 8-K
ID: 0000950170-24-036151
2024-03-04
Form 8-K
ID: 0000950170-24-024878